A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors

Saved in:
Bibliographic Details
Main Authors: Hänse, Nicole (Author) , Marmé, Frederik (Author)
Format: Article (Journal) Book/Monograph
Language:English
Published: London; Berlin; Heidelberg BioMed Central; Springer 2016
DOI:10.1186/s12885-016-2449-0
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-016-2449-0
Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-214656
Get full text
Author Notes:N. Haense, A. Atmaca, C. Pauligk, K. Steinmetz, F. Marmé, G.M. Haag, M. Rieger, O.G. Ottmann, P. Ruf, H. Lindhofer and S.-E. Al-Batran
Description
Item Description:Aus: BMC Cancer, 16 (2016), Nr. 420. pp. 1-10. ISSN 1471-2407
Physical Description:Online Resource
DOI:10.1186/s12885-016-2449-0